These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors. Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441 [No Abstract] [Full Text] [Related]
3. COVID-19 vaccines for patients with haematological conditions. Sun C; Pleyer C; Wiestner A Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822 [No Abstract] [Full Text] [Related]
9. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2. Book BAJ; Schmidt B; Foerster AMH JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612 [No Abstract] [Full Text] [Related]
10. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon. McDermott A Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611 [No Abstract] [Full Text] [Related]
11. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121 [No Abstract] [Full Text] [Related]
13. HIV and covid-19 in South Africa. Freer J; Mudaly V BMJ; 2022 Jan; 376():e069807. PubMed ID: 35086921 [No Abstract] [Full Text] [Related]
14. Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shots. Kent SJ; Juno JA EBioMedicine; 2021 Oct; 72():103586. PubMed ID: 34536815 [No Abstract] [Full Text] [Related]
15. Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients. Sesques P; Bachy E; Ferrant E; Safar V; Gossez M; Morfin-Sherpa F; Venet F; Ader F Cancer Cell; 2022 Mar; 40(3):236-237. PubMed ID: 35093212 [No Abstract] [Full Text] [Related]
16. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients. Deng Y; Li Y; Yang R; Tan W Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334 [No Abstract] [Full Text] [Related]
17. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective. Blake PG; Hladunewich MA; Oliver MJ Clin J Am Soc Nephrol; 2021 Nov; 16(11):1746-1748. PubMed ID: 34281983 [No Abstract] [Full Text] [Related]
18. Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency. Squire J; Joshi A Ann Allergy Asthma Immunol; 2021 Sep; 127(3):383-384. PubMed ID: 34022388 [No Abstract] [Full Text] [Related]
19. Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children. Yang C; Zhao H; Tebbutt SJ Front Immunol; 2021; 12():748456. PubMed ID: 34975839 [No Abstract] [Full Text] [Related]
20. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566 [No Abstract] [Full Text] [Related] [Next] [New Search]